Tag: Hatch-Waxman Act

Predicting Generic Entry: Forecasting When Your Drug Gets Generics

Jul, 3 2026| 8 Comments

Learn how to accurately predict generic drug entry using advanced forecasting models, patent analysis, and regulatory data to navigate patent cliffs and market competition.

Recent Patent Cases and Generic Delays: 2023-2025 Examples

Dec, 11 2025| 9 Comments

Despite FDA approval, generic drugs in the U.S. face average delays of 3.2 years due to patent litigation. Learn how patent thickets, the 30-month stay, and legal tactics are blocking affordable medicines for patients.